Finance / Czech Republic
Turkish Acquisition Drives Sales For Zentiva
March 2008 | Company Finance AlertIn 2007, Czech drugmaker Zentiva's sales grew by 19% to CZK16.7bn (US$1.03bn), due mainly to the acquisition of Turkish drug firm Eczacibaşi in March 2007 for EUR460mn
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
